Carl Morrison

15.4k total citations · 1 hit paper
185 papers, 8.1k citations indexed

About

Carl Morrison is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carl Morrison has authored 185 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 64 papers in Oncology and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carl Morrison's work include Cancer Immunotherapy and Biomarkers (25 papers), Cancer Genomics and Diagnostics (21 papers) and Epigenetics and DNA Methylation (15 papers). Carl Morrison is often cited by papers focused on Cancer Immunotherapy and Biomarkers (25 papers), Cancer Genomics and Diagnostics (21 papers) and Epigenetics and DNA Methylation (15 papers). Carl Morrison collaborates with scholars based in United States, United Kingdom and Germany. Carl Morrison's co-authors include Wendy L. Frankel, Kay Huebner, Carlo M. Croce, Muller Fabbri, Stefano Volinia, Stefan Costinean, Gülnur Güler, David E. Cohn, Kenneth K. Chan and Elisa Callegari and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Carl Morrison

182 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

2007 1.3k citations Muller Fabbri, Stefano Volinia et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl Morrison United States	45	4.2k	2.4k	2.3k	1.3k	922	185	8.1k
Hidewaki Nakagawa Japan	45	4.0k 0.9×	2.6k 1.1×	2.6k 1.1×	1.1k 0.8×	1.8k 2.0×	150	7.9k
Mark A. Watson United States	48	3.4k 0.8×	1.7k 0.7×	1.9k 0.8×	1.4k 1.1×	794 0.9×	129	7.2k
Cheryl Gillett United Kingdom	45	4.2k 1.0×	2.4k 1.0×	4.0k 1.7×	1.2k 1.0×	1.3k 1.4×	123	8.5k
Roberta Maestro Italy	42	4.9k 1.2×	1.5k 0.6×	2.9k 1.3×	1.8k 1.4×	833 0.9×	121	8.5k
Vladimir Lazar France	46	4.1k 1.0×	2.1k 0.9×	2.1k 0.9×	954 0.7×	607 0.7×	133	7.4k
Naohide Oue Japan	47	5.7k 1.4×	2.6k 1.1×	2.4k 1.0×	1.4k 1.0×	897 1.0×	235	8.6k
Yusuke Nakamura Japan	46	3.0k 0.7×	1.6k 0.7×	2.1k 0.9×	801 0.6×	1.2k 1.3×	134	6.6k
Giuseppe Viglietto Italy	48	5.4k 1.3×	1.6k 0.7×	2.3k 1.0×	803 0.6×	591 0.6×	150	8.2k
Chien‐Feng Li Taiwan	46	4.4k 1.0×	1.9k 0.8×	2.2k 1.0×	1.7k 1.3×	687 0.7×	322	8.2k
Yoichi Furukawa Japan	48	6.5k 1.6×	1.6k 0.7×	2.3k 1.0×	794 0.6×	959 1.0×	183	9.6k

Countries citing papers authored by Carl Morrison

Since Specialization

Citations

This map shows the geographic impact of Carl Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Morrison more than expected).

Fields of papers citing papers by Carl Morrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Morrison. The network helps show where Carl Morrison may publish in the future.

Co-authorship network of co-authors of Carl Morrison

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Morrison. A scholar is included among the top collaborators of Carl Morrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Morrison. Carl Morrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galbo, Phillip M., et al.. (2025). A Comprehensive Guide to Achieving New York State Clinical Laboratory Evaluation Program Approval for Next-Generation Sequencing Assays. Journal of Molecular Diagnostics. 27(6). 485–501. 2 indexed citations

Stephen, Bettzy, Joud Hajjar, Shrutii Sarda, et al.. (2023). T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy. Journal for ImmunoTherapy of Cancer. 11(8). e007236–e007236. 9 indexed citations

Yamauchi, Takayoshi, Toshifumi Hoki, Takaaki Oba, et al.. (2021). T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors. Nature Communications. 12(1). 1402–1402. 102 indexed citations

Gartrell, Robyn D., Douglas K. Marks, Emanuelle M. Rizk, et al.. (2019). Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma. Clinical Cancer Research. 25(8). 2494–2502. 17 indexed citations

Kumar, Rahul, Tariq A. Bhat, Ajay Kumar Chaudhary, et al.. (2019). Cytochrome c Deficiency Confers Apoptosome and Mitochondrial Dysfunction in African-American Men with Prostate Cancer. Cancer Research. 79(7). 1353–1368. 22 indexed citations

Zhang, Yali, Wiam Bshara, Gary Zirpoli, et al.. (2016). Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis. Clinical Cancer Research. 23(1). 97–103. 79 indexed citations

Zhu, Qianqian, Qiang Hu, Lori Shepherd, et al.. (2015). The Impact of DNA Input Amount and DNA Source on the Performance of Whole-Exome Sequencing in Cancer Epidemiology. Cancer Epidemiology Biomarkers & Prevention. 24(8). 1207–1213. 20 indexed citations

Williams, AnnaLynn M., Matthew R. Bonner, Heather M. Ochs‐Balcom, et al.. (2014). Dietary lignan intake and androgen receptor expression in breast tumors. Cancer Causes & Control. 26(2). 311–317. 3 indexed citations

Ademuyiwa, Foluso O., Wiam Bshara, Kristopher Attwood, et al.. (2012). NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer. PLoS ONE. 7(6). e38783–e38783. 75 indexed citations

10.

Koman, Igor, Mairead Commane, Geraldine Paszkiewicz, et al.. (2012). Targeting FACT Complex Suppresses Mammary Tumorigenesis in Her2 / neu Transgenic Mice. Cancer Prevention Research. 5(8). 1025–1035. 52 indexed citations

11.

Morrison, Carl, et al.. (2012). Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type. Histopathology. 61(3). 365–377. 40 indexed citations

12.

McCann, Susan E., Katie C. Hootman, Anne M. Weaver, et al.. (2011). Dietary Intakes of Total and Specific Lignans Are Associated with Clinical Breast Tumor Characteristics3. Journal of Nutrition. 142(1). 91–98. 26 indexed citations

13.

Luo, Wei, Adam R. Karpf, Kristin K. Deeb, et al.. (2010). Epigenetic Regulation of Vitamin D 24-Hydroxylase/ CYP24A1 in Human Prostate Cancer. Cancer Research. 70(14). 5953–5962. 78 indexed citations

14.

Morrison, Carl, Richard Cheney, Candace S. Johnson, Gary J. Smith, & James L. Mohler. (2009). Central quadrant procurement of radical prostatectomy specimens. The Prostate. 69(7). 770–773. 22 indexed citations

15.

Porter, Kyle, et al.. (2007). Semi‐automated imaging system to quantitate Her‐2/neu membrane receptor immunoreactivity in human breast cancer. Cytometry Part A. 71A(5). 273–285. 41 indexed citations

16.

Morrison, Carl, Kambiz Merati, W. Marsh, et al.. (2007). The Mucin Expression Profile of Endometrial Carcinoma and Correlation With Clinical-Pathologic Parameters. Applied immunohistochemistry & molecular morphology. 15(4). 426–431. 19 indexed citations

17.

Smith, Laura T., Romulo Martin Brena, James C. Lang, et al.. (2006). Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proceedings of the National Academy of Sciences. 103(4). 982–987. 123 indexed citations

18.

Qin, Haiyan, Dimitrios Iliopoulos, Shuho Semba, et al.. (2006). A Role for the WWOX Gene in Prostate Cancer. Cancer Research. 66(13). 6477–6481. 90 indexed citations

19.

Weber, Frank, Lei Shen, Micheala A. Aldred, et al.. (2005). Genetic Classification of Benign and Malignant Thyroid Follicular Neoplasia Based on a Three-Gene Combination. The Journal of Clinical Endocrinology & Metabolism. 90(5). 2512–2521. 122 indexed citations

20.

Baschinsky, Dmitry Y., et al.. (2002). C-erb B2 (Her2/ neu) Is Neither Overexpressed nor Amplified in Hepatic Neoplasms. Applied immunohistochemistry & molecular morphology. 10(3). 237–241. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact